Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spyre Therapeutics, Inc. | 50,200 | reported | 28 Feb 2019 | tx 4+270,200 |
| Checkmate Pharmaceuticals, Inc. | 0 | reported | 31 May 2022 | tx 9+333,898−429,814 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 May 2022 | OTHER | Checkmate Pharmaceuticals, Inc. | 95,916 | — | deriv |
| 31 May 2022 | OTHER | Checkmate Pharmaceuticals, Inc. | 150,818 | — | deriv |
| 31 May 2022 | OTHER | Checkmate Pharmaceuticals, Inc. | 27,300 | — | deriv |
| 31 May 2022 | OTHER | Checkmate Pharmaceuticals, Inc. | 101,180 | — | deriv |
| 31 May 2022 | OTHER | Checkmate Pharmaceuticals, Inc. | 54,600 | — | deriv |
| 04 Mar 2021 | GRANT_AWARD | Checkmate Pharmaceuticals, Inc. | 54,600 | 0.00 USD | deriv |
| 27 Jan 2022 | GRANT_AWARD | Checkmate Pharmaceuticals, Inc. | 101,180 | 0.00 USD | deriv |
| 04 Aug 2021 | GRANT_AWARD | Checkmate Pharmaceuticals, Inc. | 27,300 | 0.00 USD | deriv |
| 06 Aug 2020 | GRANT_AWARD | Checkmate Pharmaceuticals, Inc. | 150,818 | 0.00 USD | deriv |
| 28 Feb 2019 | GRANT_AWARD | Spyre Therapeutics, Inc. | 50,200 | 0.00 USD | deriv |
| 20 Feb 2018 | GRANT_AWARD | Spyre Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 22 Aug 2017 | GRANT_AWARD | Spyre Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 22 Aug 2017 | GRANT_AWARD | Spyre Therapeutics, Inc. | 165,000 | 0.00 USD | deriv |